Skip to content

Author

Arben Bislimi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

ADAPTING TREATMENT IN METASTATIC HR+/HER2− BREAST CANCER, AFTER CHEMOTHERAPY REFUSAL: A CASE REPORT

This study case represent breast cancer with positive hormone receptors and HER2-negative status shows the most usual subtype in metastatic breast carcinoma. Clinical management is frequently derived from endocrine therapy together with certain agents. The therapeutic option affected not only by the biological characte...

Arben Bislimi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.